Stereotactic body radiotherapy for refractory ventricular tachycardia: Still paving the road to randomized trials…

Affiliations

¹ Heart and Vascular Institute, Department of Medicine at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Electronic address: sabas@upmc.edu.
² Heart and Vascular Institute, Department of Medicine at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Editorial

Samir Saba et al. Heart Rhythm. 2024 Jan.

. 2024 Jan;21(1):25-26.

doi: 10.1016/j.hrthm.2023.10.015. Epub 2023 Oct 16.

¹ Heart and Vascular Institute, Department of Medicine at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Electronic address: sabas@upmc.edu.
² Heart and Vascular Institute, Department of Medicine at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

No abstract available

Comment on

One-year outcomes after stereotactic body radiotherapy for refractory ventricular tachycardia.
Arkles J, Markman T, Trevillian R, Yegya-Raman N, Garg L, Nazarian S, Santangeli P, Garcia F, Callans D, Frankel DS, Supple G, Lin D, Riley M, Kumaraeswaran R, Marchlinski F, Schaller R, Desjardins B, Chen H, Apinorasethkul O, Alonso-Basanta M, Diffenderfer E, Kim MM, Feigenberg S, Zou W, Marcel J, Cengel KA. Arkles J, et al. Heart Rhythm. 2024 Jan;21(1):18-24. doi: 10.1016/j.hrthm.2023.10.005. Epub 2023 Oct 11. Heart Rhythm. 2024. PMID: 37827346